Register for our free email digests:
Samsung Bioepis Co. Ltd.
Division of Samsung Electronics Co. Ltd.
www.samsungbioepis.com
Latest From Samsung Bioepis Co. Ltd.
Amgen Could Block Enbrel Biosimilars For Another Decade As Court Rules Stealth Patents Valid
Court rejects Sandoz's arguments that patents covering Enbrel's active ingredient and method of manufacture are invalid; decision comes three years after FDA approved Sandoz's biosimilar.
Amgen’s Future Looks Brighter After Ruling Lifts Threat Of Enbrel Copycat
Markets are re-assessing Amgen’s long-term value after a US judge upheld two patents relating to Amgen's blockbuster rheumatoid arthritis drug Enbrel, denying a challenge by Novartis and allowing investors to focus now on the pharma’s promising pipeline.
US Appeals Court Denies Genentech Injunction Over Amgen's 'At Risk' Trastuzumab Launch
Genentech has been denied its request for a US injunction against Amgen over its at-risk launch of a trastuzumab biosimilar rival to Herceptin.
Mylan-Biocon’s Ogivri First Off Block In Australia But Competition In Sight
Mylan-Biocon’s biosimilar Herceptin debuts in Australia, promising to provide patients a high quality and affordable alternative, though at least three competing trastuzumab versions including Amgen’s Kanjinti are in the wings.
Company Information
- Industry
-
Biotechnology
- Large Molecule
- Pharmaceuticals
- Therapeutic Areas
- Cancer
- Immune Disorders
- Metabolic Disorders
- Alias(es)
- Ownership
- Private
- Headquarters
-
Worldwide
-
Asia
-
Pacific Rim
-
South Korea
-
South Korea
-
Pacific Rim
-
Asia
- Parent & Subsidiaries
- Samsung Electronics Co. Ltd.
- Senior Management
- Christopher Hansung Ko, PhD, CEO
- Contact Info
-
Samsung Bioepis Co. Ltd.
Phone: 32 455 3114
107, Cheomdan-daero
Yeonsu-Gu
Incheon, 406-840
South Korea
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice